Jason
Grebely

  • Professor,
  • The Kirby Institute
  • Australia
In programme
  • November 23 15:00 to 16:30
  • November 23 16:50 to 18:20
  • November 23 16:50 to 18:20
  • November 24 13:20 to 14:50
View hours & dates

About

Jason is Head of the Hepatitis C and Drug Use Group in the Viral Hepatitis Clinical Research Program at the Kirby Institute, UNSW Sydney, and President of the International Network on Hepatitis in Substance Users. Jason's research is based in the field of epidemiology, with a focus on clinical epidemiology.

Hours & Dates

Wednesday, 23 November

15:00
Oral presentation

Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: the ETHOS Engage Study

15:00 to 16:30
Knowledge market 4 (K4)
Jason Grebely
16:50
Oral presentation

3. We have reached single-diagnosis and treatment for hepatitis C infection: What next?

16:50 to 18:20
Knowledge market 3 (K3)
Jason Grebely

Hepatitis C prevention and treatment among people who inject drugs: Global progress and future requirements

16:50 to 18:20
Knowledge market 3 (K3)
Structured session

Thursday, 24 November

13:20

Hepatitis C testing and treatment

13:20 to 14:50
Knowledge market 3 (K3)
Oral presentation session
View all speakers